![Rodrigo Sánchez-Bayona: Our editorial on CDK4/6i impacted the OS in first-line for HR+/HER2- advanced breast cancer](https://oncodaily.com/pub/uploads/2024/07/download-23-1280x959.png)
Photos of Rodrigo Sánchez-Bayona and Mafalda Oliveira from X
Jul 25, 2024, 00:35
Rodrigo Sánchez-Bayona: Our editorial on CDK4/6i impacted the OS in first-line for HR+/HER2- advanced breast cancer
Rodrigo Sánchez-Bayona, Medical Oncologist specialising in breast and gynecological cancers at 12 de Octubre University Hospital, posted on X:
“How have CDK4/6i impacted the OS in first-line for HR+/HER2- advanced breast cancer? Delighted to share this editorial in Annals of Oncology, coauthored with Mafalda Oliveira.”
Source: Rodrigo Sánchez-Bayona/X